Role of angiotensin in renal sympathetic activation in nephrotic syndrome
Department of Internal Medicine, University of Iowa College of Medicine; and Veterans Administration Medical Center, Iowa City, Iowa 52242 The effect of type 1 angiotensin II receptor antagonist treatment (losartan) on cardiac baroreflex regulation of renal sympathetic nerve activity (RSNA) and rena...
Saved in:
Published in | American journal of physiology. Regulatory, integrative and comparative physiology Vol. 274; no. 3; pp. 808 - R813 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.1998
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Department of Internal Medicine, University of Iowa College of
Medicine; and Veterans Administration Medical Center, Iowa City,
Iowa 52242
The effect of type
1 angiotensin II receptor antagonist treatment (losartan) on cardiac
baroreflex regulation of renal sympathetic nerve activity (RSNA) and
renal sodium handling in rats with nephrotic syndrome was examined.
After intravenous losartan administration, with arterial pressure
normalized by intravenous methoxamine, basal RSNA was decreased 14 ± 3% in arterial baroreceptor-intact rats and by 21 ± 5% in
arterial baroreceptor-denervated rats. Intracerebroventricular
losartan, which did not affect arterial pressure, decreased basal RSNA
activity by 15 ± 1%. Both intravenous and intracerebroventricular
losartan augmented the renal sympathoinhibitory response to acute
volume loading, and this was associated with an enhanced natriuretic
response to the acute volume load. In nephrotic syndrome, acute
losartan administration improved cardiac baroreflex regulation of RSNA,
which was associated with improved ability to excrete acute sodium
loads.
losartan; renal sympathetic nerve activity; cardiac baroreflex; sodium |
---|---|
ISSN: | 0363-6119 0002-9513 1522-1490 |
DOI: | 10.1152/ajpregu.1998.274.3.r808 |